Salubrious effect of Kalpaamruthaa, a modified indigenous preparation in adjuvant-induced arthritis in rats-A biochemical approach

Chemico-Biological Interactions

Volumn 173, Issue 2, 2008, Pages 148-158

  Mythilypriya, Rajendran ^a   Shanthi, Palanivelu ^a   Sachdanandam, Panchanadam ^a  

^a UNIVERSITY OF MADRAS   (India)

Author keywords

Adjuvant induced arthritis; Emblica officinalis; Hypolipidemic effect; Kalpaamruthaa; Semecarpus anacardium nut

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; ASCORBIC ACID; ASPARTATE AMINOTRANSFERASE; CHOLESTEROL; CREATININE; DNA; EMBLICA OFFICINALIS EXTRACT; FATTY ACID; FLAVONOID; GLOBULIN; GLUCOSE; HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN; KALPAAMRUTHAA; LOW DENSITY LIPOPROTEIN; PROTEIN; RNA; SEMECARPUS ANACARDIUM EXTRACT; TANNIN DERIVATIVE; UREA; URIC ACID; VERY LOW DENSITY LIPOPROTEIN;

ADJUVANT ARTHRITIS; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DNA DAMAGE; ERYTHROCYTE COUNT; ERYTHROCYTE SEDIMENTATION RATE; FRUIT; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HONEY; LEUKOCYTE COUNT; MALE; NONHUMAN; PROTEIN BLOOD LEVEL; RAT; THROMBOCYTE COUNT; UREA BLOOD LEVEL; URIC ACID BLOOD LEVEL;

ALANINE TRANSAMINASE; ANIMALS; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; ASPARTATE AMINOTRANSFERASES; BLOOD CELL COUNT; BLOOD CHEMICAL ANALYSIS; DNA FRAGMENTATION; HEMOGLOBINS; KIDNEY; LIPID METABOLISM; LIVER; MALE; PHYTOTHERAPY; PLANT EXTRACTS; RATS; RATS, WISTAR; SEMECARPUS; URINALYSIS;

ANIMALIA; PHYLLANTHUS EMBLICA; RATTUS; SEMECARPUS ANACARDIUM;

EID: 43049172135     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2008.02.007     Document Type: Article

References (121)

1. Yeom M.J., Lee H.C., Kim G.H., Lee H.J., Shim I., Oh S.K., Kang S.K., and Hahm D.H. Anti-arthritic effects of Ephedra sinica STAPF herb-acupuncture: inhibition of lipopolysaccharide-induced inflammation and adjuvant-induced polyarthritis. J. Pharmacol. Sci. 100 (2006) 41-50
2. Scott D.L., Shipley M., Dawson A., Edwards S., Symons D.P., and Woolf A.D. The clinical management of rheumatoid arthritis and osteoarthritis: strategies for improving clinical effectiveness. Br. J. Rheumatol. 37 (1998) 546-554
3. R. Mythilypriya, P. Shanthi, P. Sachdanandam, Oral acute and subacute toxicity studies with Kalpaamruthaa, a modified indigenous preparation, on rats, J. Health Sci. 54 (2007) 351-358.
4. R. Mythilypriya, P. Shanthi, P. Sachdanandam, Restorative and synergistic efficacy of Kalpaamruthaa, a modified Siddha preparation, on an altered antioxidant status in adjuvant induced arthritic rat model, Chem. Bio. Int. 168 (2007) 193-202
5. Arulkumaran S., Ramprasath V.R., Shanthi P., and Sachdanandam P. Alteration of DMBA-induced oxidative stress by additive action of a modified indigenous preparation-Kalpaamruthaa. Chem. Biol. Interact. 167 (2007) 99-106
6. R. Mythilypriya, P. Shanthi, P. Sachdanandam, Analgesic, antipyretic and Ulcerogenic properties of an indigenous formulation-Kalpaamruthaa, Phytother. Res. 21 (2007) 574-578.
7. Veena K., Shanthi P., and Sachdanandam P. Anticancer effect of Kalpaamruthaa on mammary carcinoma in rats with reference to glycoprotein components, lysosomal and marker enzymes. Biol. Pharm. Bull. 29 (2006) 565-569
8. Veena K., Shanthi P., and Sachdanandam P. The biochemical alterations following administration of Kalpaamruthaa and Semecarpus anacardium in mammary carcinoma. Chem. Biol. Interact. 161 (2006) 69-78
9. Murthy S.S.N. A bioflavanoid from Semecarpus anacardium. Phytochemistry 22 (1983) 1518-1520
10. Murthy S.S.N. Jeediflavanone-a bioflavanoid from Semecarpus anacardium. Phytochemistry 24 (1985) 1065-1069
11. Murthy S.S.N. Naturally occurring biflavanoid derivatives part VII galluflavanone a new flavanoid from Semecarpus anacardium Linn. Indian J. Chem. 24 (1985) 398-402
12. Murthy S.S.N. New dimeric flavone from Semecarpus anacardium Linn. Proc. Indian Natl. Sci. Acad. 53 (1987) 632-636
13. Murthy S.S.N. Naturally occurring biflavanoid derivatives. Part X. Semecarpetin, a bioflavonone from Semecarpus anacardium. Phytochemistry 27 (1988) 3020-3022
14. Murthy S.S.N. New bioflavonoid from Semecarpus anacardium Linn. Clin. Acta Turcica 20 (1992) 33-37
15. Bors W., Michel C., and Schikora S. Interaction of flavonoids with ascorbate and determination of their univalent redox potentials: a pulse radiolysis study. Free Radic. Biol. Med. 19 (1995) 45-52
16. Ghosal S., Tripathi V.K., and Chouhan S. Active constituents of Emblica officinalis. Part I. The chemistry and anti-oxidant effect of two new hydrolysable tannins, Emblicanin A & B. Indian J. Chem. 35 (1996) 941-948
17. Ramprasath V.R., Shanthi P., and Sachdanandam P. Antiinflammatory effect of Semecarpus anacardium Linn. Nut extract in acute and chronic inflammatory conditions. Biol. Pharm. Bull. 27 (2004) 2028-2031
18. Ramprasath V.R., Shanthi P., and Sachdanandam P. Immunomodulatory and anti-inflammatory effects of Semecarpus anacardium Linn. Nut milk extract in experimental inflammatory conditions. Biol. Pharm. Bull. 29 (2006) 693-700
19. Premalatha B. Semecarpus anacardium Linn. nuts-a boon in alternative medicine. Indian J. Exp. Biol. 38 (2000) 1177-1182
20. Sharma A., Mathur R., and Dixit V.P. Hypocholesterolemic activity of nut shell extract of Semecarpus anacardium (Bhilawa) in cholesterol fed rabbits. Indian J. Exp. Biol. 33 (1995) 444-448
21. Bhattacharya A., Chatterjee A., Ghosal S., and Bhattacharya S.K. Antioxidant activity of active tannoid principles of Emblica officinalis (amla). Indian J. Exp. Biol. 37 (1991) 676-680
22. Jose J.K., Kuttan G., and Kuttan R. Antitumour activity of Emblica officinalis. J. Ethnopharmacol. 75 (2001) 65-69
23. Mathur R., Sharma V.P., and Varma D.M. Hypolipidemic effect of fruit juice of Emblica officinalis in cholesterol fed rabbits. J. Ethnopharmacol. 50 (1996) 61-68
24. Sairam K., Rao Ch.V., Babu M.D., Kumar K.V., Agrawal V.K., and Goel R.K.K. Antiulcerogenic effect of methanolic extract of Emblica officinalis: an experimental study. J. Ethnopharmacol. 82 (2002) 1-9
25. Ganju L., Karan D., Chanda S., Srivastava K.K., Sawhney R.C., and Selvamurthy W. Immunomodulatory effects of agents of plant origin. Biomed. Pharmacother. 57 (2003) 296-300
26. Connor J.R., Manning P.T., Settle S.L., Moore W.M., Jetome G.M., Webber R.K., Tjoeng F.S., and Currie M.G. Suppression of adjuvant induced arthritis by selective inhibition of inducible nitric oxide synthase. Eur. J. Pharmacol. 273 (1995) 15-24
27. Formulary of Siddha Medicine (1972), Indian Medical Practitioners Co-operative Pharmacy and Stores Ltd., Madras, India p. 197
28. Vijayalakshmi T., Muthulakshmi V., and Sachdanandam P. Effect of the milk extract of Semecarpus anacardium nut on adjuvant arthritis-a dose-dependent study in Wistar albino rats. Gen. Pharmacol. 27 (1996) 1223-1226
29. R. Mythilypriya, P. Shanthi, P. Sachdanandam, Therapeutic effect of Kalpaamruthaa, a herbal preparation on adjuvant induced arthritis in Wistar rats, Inflammopharmacology 16 (2008) 21-35
30. Dacie J.V., and Lewis S.M. Practical Hematology (1977), Churchill Livingstone, Edinburgh
31. Sasaki T., and Matsui S. Effect of acetic acid concentration on the colour reaction in the o-toludine boric acid for blood glucose determination. Rinsho Kagaku 1 (1972) 346-353
32. Natelson S., Scott M.L., and Beffa C. A rapid method for the estimation of urea in biological fluid by means of the reaction between diacetely and urea. Am. J. Clin. Pathol. 21 (1951) 275-281
33. Lowry O.H., Rosenbrough N.J., Farn A.L., and Randall R.J. Protein measurement with Folin's phenol reagent. J. Biol. Chem. 193 (1951) 176-265
34. Caraway W.T. Uric acid. In: Seligson D. (Ed). Standard Methods of Clinical Chemistry (1963), Academic Press, New York 239-247
35. Owen J.A., Iggo T.B., Scandrett F.J., and Stemart I.P. Determination of creatinine in plasma (or) serum and in urine. Biochem. J. 58 (1954) 426-437
36. King J. The phosphohydrolases-acid and alkaline phosphatases. In: Van D. (Ed). Practical Clinical Enzymology (1965), Nostrand Company Limited 191-208
37. Parekh A.C., and Jung D.H. Cholesterol determination with ferric chloride-uranyl acetate and sulphuric acid ferrous sulphate reagents. Anal. Biochem. 42 (1970) 1423-1427
38. Rice E.W. Triglycerides in serum. Standard Methods of Clinical Chemistry vol. 6 (1970), Academic Press pp. 215-222
39. Van Handel E. Suggested modifications of the micro determination of triglycerides. Clin. Chem. 7 (1961) 249-251
40. Rouser G., Fkeischer S., and Yamamoto A. Two dimensional then layer chromatographic separation of polar lipids and determination of phospholipids by phosphorus analysis of spots. Lipids 5 (1970) 494-496
41. Itaya K. A more sensitive and stable colorimetric determination of free fatty acid in plasma. J. Lipid Res. 18 (1977) 653-665
42. Folch J., Lees M., and Sloane Stanley G.H. A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 226 (1957) 497-509
43. Wilson D.E., and Spiger M.J. A dual precipitation method for quantitative plasma lipoprotein measurement without ultracentrifugation. J. Lab Clin. Med. 82 (1973) 473-482
44. Schneider W.C. In: Colowick S.P., and Kaplan N.O. (Eds). Methods in Enzymology vol. 3 (1957), Academic Press, New York 680-685
45. Burton K. The study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxy ribonucleic acid. Biochem. J. 62 (1956) 315-323
46. Rawal U.M., Patel U.S., Rao G.N., and Desai R.R. Clinical and biochemical studies on cateractous human lens. III. Quantitative study of protein, RNA and DNA. Arogya J. Health Sci. 3 (1977) 69-72
47. Musson R.A. Human monocyte maturation/differentiation during in vitro culture. Surv. Immunol. Res. 2 (1983) 246-251
48. Yokozawa T., and Dong E. Role of ginsenoside-RD in cisplatin induced renal injury: special reference to DNA fragmentation. Nephron 89 (2001) 433-438
49. Agarwal R.B., and Rangari V.D. Phytochemical investigation and evaluation of anti-inflammatory and anti-arthritic activities of essential oil of Strobilanthus ixiocephala Benth. Indian J. Exp. Biol. 41 (2003) 890-894
50. Hochberg M.C., Arnold C.M., Hogans B.B., and Spivak J.L. Serum immunoreactive erythropoietin in rheumatoid arthritis: impaired response to anemia. Arthritis Rheum. 31 (1988) 1318-1321
51. Mowat A.G. Anaemia in rheumatoid arthritis. Mod. Trends. Rheumatol. 2 (1971) 106-116
52. Connolly K.M., Stecher V.J., Danis E., Pruden D.J., and LaBrie T. Alteration of interleukin-1 activity and the acute phase response in adjuvant arthritic rats treated with disease modifying antirheumatic drugs. Inflamm. Res. 25 (1988) 94-105
53. Klempner M.S., Dinarello C.A., and Gallin J.I. Human leukocytic pyrogen induces release of specific granule contents from human neutrophils. J. Clin. Invest. 61 (1978) 1330-1336
54. Selph J.L., Boncek V.M., Soroko F.E., Harris T.M., and Cochran F.R. The pharmacologic evaluation of locomotor activity versus inflammatory parameters in rat adjuvant arthritis. Agents Actions 39 (1993) C201-C203
55. Choi J., Huh K., Kim S.H., Lee K.T., Kwon S.H., and Park H.J. Toxicology of Kalopanax pictus extract and hematological effect of the isolated anti-rheumatoidal kalopanaxsaponin A on the Freunds complete adjuvant reagent-treated rat. Arch. Pharm. Res. 24 (2001) 119-125
56. Maria M., Engeniusz M., Miroslaw K., Maria K., and Iwona P. Adjuvant induced disease in rats. Clinical findings and morphological and biochemical changes in blood and histological changes in internal organs. Rheumatologia 21 (1983) 213-245
57. Marcelletti J.F., and Nakamura R.M. Assessment of serological markers associated with rheumatoid arthritis. Diagnostic autoantibodies and conventional disease activity markers. Clin. Appl. Immunol. Rev. 4 (2003) 109-123
58. Skogh T., Gustafsson D., Kjellberg M., and Husberg M. Twenty eight joint count disease activity score in recent onset rheumatoid arthritis using C reactive protein instead of erythrocyte sedimentation rate. Ann. Rheum. Dis. 62 (2003) 681-682
59. Lowe J.S. Serum protein changes in rats with arthritis induced by mycobacterial adjuvant. Biochem. Pharmacol. 13 (1964) 633-641
60. Fahim A.T., Abd-EI Fattah A.A., Agha A.M., and Gad M.Z. Effect of pumpkin seed oil on the level of free radical scavengers induced during adjuvant-arthritis in rats. Pharmacol. Res. 31 (1995) 73-79
61. Sakai A., Hirano T., Okazaki R., Okimoto N., Tanaka K., and Nakamura T. Large-dose ascorbic acid administration suppresses the development of arthritis in adjuvant-infected rats. Arch. Orthop. Trauma Surg. 119 (1999) 121-126
62. Cawthorne M.A., Palmer E.D., and Green J. Adjuvant-induced arthritis and drug-metabolizing enzymes. Biochem. Pharmacol. 25 (1976) 2683-2688
63. Lorber A., Leeb J., Carroll Jr. P., Baumgartner W., and Hill V. Protein sulphydryl depression during adjuvant arthritis. Ann. Rheum. Dis. 34 (1975) 346-349
64. Lewis E.J., Bishop J., and Aspinall S.J. A simple inflammation model that distinguishes between the actions of anti-inflammatory and anti-rheumatic drugs. Inflamm. Res. 47 (1998) 26-35
65. Kohn A., and Barchet E. Correlation between albumin permeability and adenosine cyclic monophosphate levels in incubated rat mesentry tissue. C. R. Seances Soc. Biol. Fil. 170 (1976) 270-330
66. Vijayalakshmi T., Jayaprakash Narayanan P., and Sachdanandam P. Changes in glucose metabolising enzymes in adjuvant arthritis and its treatment with a Siddha drug: Serankottai Nei. Indian J. Pharmacol. 30 (1998) 89-93
67. Whiteman M., Ketsawatsakul U., and Halliwell B. A reassessment of the peroxynitrite scavenging activity of uric acid. Ann. N. Y. Acad. Sci. 962 (2002) 242-259
68. Grootveld M., and Halliwell B. Measurement of allantoin and uric acid in human body fluids. A potential index of free-radical reactions in vivo?. Biochem. J. 243 (1987) 803-808
69. Bezerra M.M., Brain S.D., Greenacre S., Jeronimo S.M., de Melo L.B., Keeble J., and da Rocha F.A. Reactive nitrogen species scavenging, rather than nitric oxide inhibition, protects from articular cartilage damage in rat zymosan-induced arthritis. Br. J. Pharmacol. 141 (2004) 172-182
70. Lawson A.A.H., and Maclean N. Renal disease and drug therapy in rheumatoid arthritis. Ann. Rheum. Dis. 25 (1966) 441-449
71. Burry H.C. Reduced glomerular function in rheumatoid arthritis. Ann. Rheum. Dis. 31 (1972) 65-68
72. Boers M. Renal disorders in rheumatoid arthritis. Semin. Arthritis Rheum. 20 (1990) 57-68
73. Pedersen L.M., Nordin H., Svensson B., and Bliddal H. Microalbuminuria in patients with rheumatoid arthritis. Ann. Rheum. Dis. 54 (1995) 189-192
74. Filho P.Y., Bracht A., Ishii-Iwato E.L., Lousano S.H., Bracht L., and Kelmer-Bracht A.M. The urea cycle in the liver of arthritic rats. Mol. Cell. Biochem. 243 (2003) 97-106
75. Kataoka H., Horiyama S., Yamaki M., et al. Anti-inflammatory and anti-allergic activities of hydroxylamine and related compounds. Biol. Pharm. Bull. 25 (2002) 1436-1441
76. Rainsford K.D. Adjuvant polyarthritis in rats: is this a satisfactory model for screening anti-arthritic drugs?. Agents Actions 12 (1982) 452-458
77. Myles Glenn B., Jack Gray D.V.M., and Kooyers W. Chemical changes in adjuvant induced polyarthritis of rats. Ann. J. Ven. Res. 26 (1965) 1195-1203
78. Niino-Nanke Y., Akama H., Hara M., and Kashiwazaki S. Alkaline phasphatase (ALP) activity in rheumatoid arthritis-its clinical significance and synthesis of ALP in RA synovium. Ryumachi 38 (1998) 581-588
79. Rehman Q., and Lane N.E. Bone loss. Therapeutic approaches for preventing bone loss in inflammatory arthritis. Arthritis Res. 3 (2001) 221-227
80. Fries J.F., Singh G., Lenert L., and Furst D.E. Aspirin, hydroxychloroquine and hepatic enzyme abnormalities with methotrexate in rheumatoid arthritis. Arthritis Rheum. 33 (1990) 1611-1619
81. Prete P.E., and Gurakar-Osborne A. The contribution of synovial fluid lipoproteins to the chronic synovitis of rheumatoid arthritis. Prostaglandins 54 (1997) 689-698
82. Park Y.B., Lee S.K., Lee W.K., Suh C.H., Lee C.W., Lee C.H., Song C.H., and Lee J. Lipid profiles in untreated patients with rheumatoid arthritis. J. Rheumatol. 26 (1999) 1701-1704
83. Situnayake R.D., and Kitas G. Dyslipidaemia and rheumatoid arthritis. Ann. Rheum. Dis. 56 (1997) 341-342
84. Rantapaa-Dahlqvist S., Wallberg-Jonsson S., and Dahlen G. Lipoprotein (a), lipids, and lipoproteins in patients with rheumatoid arthritis. Ann. Rheum. Dis. 50 (1991) 366-368
85. Dessein P.H., Stanwix A.E., and Joffe B.I. Cardiovascular risk in rheumatoid arthritis versus osteoarthritis: acute phase response related decreased insulin sensitivity and high-density lipoprotein as well as clustering of metabolic syndrome features in rheumatoid arthritis. Arthritis Res. 4 (2002) R5
86. Gonzalez-Gay M.A., Gonzalez-Juanatey C., and Martin J. Rheumatoid arthritis: a disease associated with accelerated atherogenesis. Semin. Arthritis Rheum. 35 (2005) 8-17
87. Allanore Y., Kahan A., Sellam J., Ekindjian O.G., and Borderie D. Effects of repeated infliximab therapy on serum lipid profile in patients with refractory rheumatoid arthritis B. Clin. Chim. Acta 365 (2006) 143-148
88. Billingham M.E.J. Models of arthritis and the search for antiarthritic drugs. Pharmacol. Ther. 21 (1983) 389-428
89. Roback J. Adjuvant induced and carrageenan induced inflammation and lipid peroxidation in rat liver, spleen and lungs. Biochem. Pharmacol. 27 (1978) 531-533
90. Kunitomo M., Yamaguchi Y., Futugawa Y., Hamaguchi Y., and Bando Y. Suppression of adjuvant arthritis in rats by cholesterol. Jpn. J. Pharmacol. 44 (1987) 15-22
91. Kitagawa S., Yamaguchi Y., Imaizumi N., Kunitomo M., and Fujiwara M. Auniform alteration in serum lipid metabolism occurring during inflammation in mice. Jpn. J. Pharmacol. 58 (1992) 37-46
92. Memon R.A., Grunfeld C., Moser A.H., and Feingold K.R. Tumor necrosis factor mediates the effect of endotoxin on cholesterol and triglyceride metabolism in mice. Endocrinology 132 (1993) 2246-2253
93. Lawler Jr. J.F., Yin M., Diehl A.M., Roberts E., and Chatterjee S. Tumor necrosis factor-alpha stimulates the maturation of sterol regulatory element binding protein-1 in human hepatocytes through the action of neural shingomyelinase. J. Biol. Chem. 273 (1998) 5053-5059
94. Yamaguchi Y., Tanaka Y., Yamada K., Bando Y., and Kunitomo M. Abnormal lipid metabolism in adjuvant arthritic rats. Jpn. J. Pharmacol. 50 (1989) 377-383
95. Steinmetz A., Hocke G., Saile R., and Fruchart R.P. Influence of serum amyloid A on cholesterol esterification in human plasma. Biochim. Biophys. Acta 1006 (1989) 173-178
96. 450 levels and activities in mice. Life Sci. 40 (1987) 2331-2336
97. Kawakami M. Cerami, studies of endotoxin-induced decrease in lipoprotein lipase activity. J. Exp. Med. 154 (1981) 631-639
98. Kawakami M., Murase T., Itakura H., Yamada N., Ohasawa N., and Takaku F. Lipid metabolism in endotoxic rats: decrease in hepatic triglyceride lipase activity. Microbiol. Immunol. 30 (1986) 849-854
99. Grunfeld C., and Feingold K.R. Role of cytokines in inducing hyperlipidemia. Diabetes 41 (1992) 97-101
100. Munro R., Morisson E., McDonald A.G., Hunter J.A., Madhok R., and Capell H.A. Effect of disease modifying agents on the lipid profiles of patients with rheumatoid arthritis. Ann. Rheum. Dis. 56 (1997) 374-377
101. Masoro E.J. Fat metabolism in normal and abnormal status. Am. J. Clin. Nutr. 30 (1977) 1311-1320
102. Olhagen B. On the aetiopathogenesis of rheumatoid arthritis. Ann. Clin. Res. 7 (1975) 119-128
103. Johansson C., Rossner S., and Wallidius G. HDL secretion from human intestinal tract (Letter). Lancet 11 (1978) 324-325
104. Boers M., Nurmohamed M.T., Doelman C.J.A., et al. Influence of glucocorticoids and disease activity on total and high density lipoprotein cholesterol in patients with rheumatoid arthritis. Ann. Rheum. Dis. 62 (2003) 842-845
105. Lee Y.H., Choi S.J., Ji J.D., Seo H.S., and Song G.G. Lipoprotein (a) and lipids in relation to inflammation in rheumatoid arthritis. Clin. Rheumatol. 19 (2000) 324-325
106. Hilaly J.El., Isrili Z., and Badiaa L. Acute and chronic toxicological studies of Ajuga iva in experimental animals. J. Ethanopharmacol. 91 (2004) 43-50
107. Ginter E. Ascorbic acid in cholesterol and bile acid metabolism. Ann. N. Y. Acad. Sci. 258 (1975) 410-421
108. Koseki M., Kitabatake N., Doi E., Yasuno T., Ogino S., Kazama M., and Doguchi M. Binding of taurocholate by pectin in the presence of calcium ions. J. Federal Sci. 52 (1987) 1744-1745
109. Wong N.C. The beneficial effects of plants sterols on serum cholesterol. Can. J. Cardiol. 17 (2001) 715
110. Tak P.P., Klapwijk M.S., Broersen S.F., van de Geest D.A., Overbeek M., and Firestein G.S. Apoptosis and p53 expression in rat adjuvant arthritis. Arthritis Res. 2 (2000) 229-235
111. Firestein G.S., Yeo M., and Zvaifler N.J. Apoptosis in rheumatoid arthritis synovium 96 (1995) 1631-1638
112. Nakajima T., Aono H., Hasunuma T., Yamamoto K., Shirai T., Hirohata K., and Nishioka K. Apoptosis and functional Fas antigen in rheumatoid arthritis synoviocytes. Arthritis Rheum. 38 (1995) 485-491
113. Hitchon C.A., and El-Gabalawy H.S. Oxidation in rheumatoid arthritis. Arthritis Res. Ther. 6 (2004) 265-278
114. Tak P.P., Zvaifler N.J., Green D.R., and Firestein G.S. Rheumatoid arthritis and p53: how oxidative stress might alter the course of inflammatory diseases. Immunol. Today 21 (2000) 78-82
115. Bashir S., Harris G., Denman M.A., Blake D.R., and Winyard P.G. Oxidative DNA damage and cellular sensitivity to oxidative stress in human autoimmune diseases. Ann. Rheum. Dis. 52 (1993) 659-666
116. Hajizadeh S., DeGroot J., TeKoppele J.M., Tarkowski A., and Collins L.V. Extracellular mitochondrial DNA and oxidatively damaged DNA in synovial fluid of patients with rheumatoid arthritis. Arthritis Res. Ther. 5 (2003) R234-R240
117. Ramprasath V.R., Shanthi P., and Sachdanandam P. Semecarpus anacardium Linn. nut milk extract, an indigenous drug preparation, modulates reactive oxygen/nitrogen species levels and antioxidative system in adjuvant arthritic rats. Mol. Cell. Biochem. 276 (2005) 97-104
118. Hilliquin P., Borderie D., Hernvann A., Menkes C.J., and Ekindjian O.G. Nitric oxide as S-nitroso proteins in rheumatoid arthritis. Arthritis Rheum. 40 (1997) 1512-1517
119. Vijayalakshmi T., Muthulakshmi V., and Sachdanandam P. Effect of milk extract of Semecarpus anacardium nuts on glycohydrolases and lysosomal stability in adjuvant arthritis in rats. J. Ethnopharmacol. 58 (1997) 1-8
120. Firestein G.S., Echeverri F., Yeo M., Zvaifler N.J., and Green D.R. Somatic mutations in the p53 tumour suppressor gene in rheumatoid arthritis synovium. Proc. Natl. Acad. Sci. 94 (1997) 10895-10900
121. Yamanishi Y., Boyle D.L., Rosengren S., Green D.R., Zvaifler N.J., and Firestein G.S. Regional analysis in rheumatoid arthritis synovium. Proc. Natl. Acad. Sci. 99 (2002) 10025-10030